Abstract
Objectives EEG effects of the sustained-release form of sodium valproate (SR-VPA) are unknown, although it is widely used in Chinese patients with generalized tonicclonic seizures (GTCS). Methods Fourteen newly diagnosed, untreated GTCS patients were recruited and treated with SR-VPA. Waking EEG was recorded and analyzed by way of quantitative pharmaco-electroencephalogram (QPEEG) analysis during the three-month follow-up. Results There was a statistically significant decrease in the absolute power of the delta band (P < 0.05), theta band (P < 0.03) and partial alpha-1 band (p < 0.05) with treatment compared to before treatment, while there was no significantly different absolute power between one-month and three-months after treatment. There was a strong correlation between the decrease in absolute power and the degree of the initial abnormality in all frequency bands. Two of 14 patients experienced seizures during the second month after initiation of SR-VPA therapy. Conclusions SR-VPA selectively decreased the activity of the abnormal EEG synchronization in a use-dependent manner. The reduced theta, delta, and partial alpha-1 absolute power may reflect or confirm the efficacy of SR-VPA on patients with GTCS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Annegers JF. The epidemiology of epilepsy. In: Wyllie E, ed. The treatment of epilepsy principles and practice. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2001,132.
Cho JR, Koo DL, Joo EY et al (2012) Effect of levetiracetam monotherapy on background EEG activity and cognition in drug naïve epilepsy patients. Clin Neurophysiol 123(5):883–891
Clemens B (2008) Valproate decreases EEG synchronization in a use dependent manner in idiopathic generalized epilepsy. Seizure 17(3):224–233
Clemens B, Szigeti G, Barta Z (2000) EEG frequency profiles of idiopathic generalised epilepsy syndromes. Epilepsy Res 42(2–3):105–115
Clemens B, Menes A, Nagy Z (2004) Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine. Acta Neurol Scand 109:324–329
Clemens B, Bessenyei M, Piros P et al (2007) Characteristic distribution of interictal brain electrical activity in idiopathic generalized epilepsy. Epilepsia 48(5):941–949
Commission ILAE (1997) Report. The epidemiology of the epilepsies: future direction. Epilepsia 38(5):614–618
Cotariu D, Zaidman JL, Evans S (1990) Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system. Prog Neurobiol 34(4):343–354
Fingelkurts AA, Fingelkurts AA, Kähkönen S (2005) New perspectives in pharmaco- electroencephalography. Prog Neuropsychopharmacol Biol Psychiatry 29(2):193–9
Frost JD, Hrachovy RA, Glaze DG et al (1995) Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. J Clin Neurophysiol 12:57–63
Goldberg JF, Burdick KE (2001) Cognitive side effects of anticonvulsants. J Clin Psychiatry 62(S14):27–33
Halatchev VN (2000) Epidemiology of epilepsy-recent achievements and future. Folia Mod (Plovdiv) 42(2):17
Kondakor I, Toth M, Wackermann J et al (2005) Distribution of spatial complexity of EEG in idiopathic generalized epilepsy and its change after chronic valproate therapy. Brain 18(2):115–123
Löscher W (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58(1):31–59
Meador KJ, Baker GA, Browning N et al (2009) Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360:1597–1605
Nuwer MR, Lehmann D, da Lopes Silva A (1994) IFCN guidelines for topographic and frequency analysis of EEGs and EPs. Report of an IFCN committee. International federation of clinical neurophysiology. Electroencephalogr Clin Neurophysiol 91(1):1–5
Ortinski P, Kimford JM (2004) Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5(S1):60–65
Salinksy MC, Oken BS, Storzbach D et al (2003) Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. Epilepsia 44:1042–1050
Salinsky MC, Binder LM, Oken BS et al (2002) Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 43:482–490
Veauthier J, Haettig H, Meencke HJ (2009) Impact of levetiracetam add-on therapy on different EEG occipital frequencies in epileptic patients. Seizure 18:392–395
Vining EPG (2010) Another nail in the coffin. Epilepsy Curr 10(3):53–54
Wang W, Wu J, Wang D et al (2003) The prevalence and treatment gap in epilepsy in china: an ILAE/IBE/WHO study. Neurology 60(9):1544–1545
Willoughby JO, Fitzgibbon SP, Pope KJ et al (2003) Persistent abnormality detected in the non-ictal electroencephalogram in primary generalised epilepsy. J Neurol Neurosurg Psychiatry 74:51–55
Zeng KB, Xf W, Xi ZQ et al (2010) Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Clin Neurol Neurosurg 112(4):291–295
Acknowledgments
The study was supported by Chongqing Health Bureau Fund, China (No.2011–2–118 to KBZ) and a grant from Science Foundation of Chongqing Science and Technology Commission, China (CSTC2012jjA0208 to KBZ). We thank Elena A. Kharlamov for assistance in the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guo, J., Wang, D., Ren, M. et al. QPEEG analysis of the effects of sodium valproate on adult Chinese patients with generalized tonic-clonic seizures. Metab Brain Dis 29, 801–807 (2014). https://doi.org/10.1007/s11011-014-9561-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-014-9561-0